Intrinsic Factor IgG Antibody

Intrinsic factor antibody IgG are autoimmune antibodies directed against intrinsic factor, a gastric protein essential for vitamin B12 absorption. These IgG antibodies block intrinsic factor’s binding to vitamin B12 or damage parietal cells, causing impaired B12 uptake and pernicious anemia. Detection in blood supports diagnosis of autoimmune B12 deficiency; affected patients often need lifelong B12 replacement, commonly by intramuscular injections.

If intrinsic factor is positive, it means your blood contains antibodies against intrinsic factor, indicating autoimmune damage to stomach cells. This commonly causes pernicious anemia by blocking vitamin B12 absorption, leading to fatigue, neuropathy and cognitive problems. It typically prompts testing of B12 and methylmalonic acid, and treatment with B12 replacement (often injections) plus monitoring for gastric atrophy and related complications.

The antibody tests for pernicious anemia detect intrinsic factor antibodies (binding and blocking) and anti-parietal cell antibodies. Intrinsic factor antibodies are highly specific for pernicious anemia; anti-parietal cell antibodies are more sensitive but less specific. These serologic tests support diagnosis alongside low vitamin B12 and elevated methylmalonic acid or homocysteine. A positive intrinsic factor antibody test strongly indicates pernicious anemia.

Pernicious anemia, an autoimmune form of chronic atrophic gastritis, causes low or absent intrinsic factor. Autoantibodies target gastric parietal cells and intrinsic factor, reducing intrinsic factor production and impairing vitamin B12 absorption in the terminal ileum. This leads to megaloblastic anemia and neurological symptoms if untreated; diagnosis involves antibody testing and B12 level assessment.

A positive IgG test means your immune system has produced antibodies from a past infection or vaccination. It usually indicates prior exposure and some degree of immunity, but doesn’t prove current active infection or complete protection. Interpretation depends on timing, symptoms, and vaccine history. Discuss results with your clinician, who may recommend further testing (e.g., PCR or neutralizing antibody titers) if needed.

With timely diagnosis and lifelong vitamin B12 replacement, people with pernicious anemia generally have a normal life expectancy. Untreated or delayed treatment can cause irreversible neurological damage, anemia-related complications, higher morbidity, and reduced life expectancy. Regular monitoring and adherence to injections or high‑dose oral B12 prevents complications and preserves quality and length of life.